Latest Biotech (general) News
Biotech East Explores Intersection of Science and Business
Asst. Prof. Denise Dunlap poses with alum Bill Yelle, right, and panelists Brian Hess and Assoc. Prof. Carl Lawton during the Biotech East visit to M2D2.
Updated: 06/21/2019 03:00A
Biotech Investors Are Flocking to Paris
Biotech investors around the globe are flocking to HealthTech Investor Days, an event sponsored by France Biotech, an association of French entrepreneurs in ...
Updated: 06/20/2019 04:01P
Congress Targets China’s Biotech Ambitions
Biotech is joining chips and telecommunications at the forefront of the U.S.-China technology war, with Congress unveiling a series of measures, including one ...
Updated: 06/20/2019 11:49A
MBI's Worcester expansion should get more biotech startups off the ground
Inside dozens of closet-sized laboratories in three different Worcester buildings is a goldmine of biotechnology brainpower and promising research just waiting ...
Updated: 06/20/2019 03:00A
Harry Boxer’s three biotech stocks on the move include Nektar Therapeutics
Also in focus: G1 Therapeutics and Iovance Biotherapeutics.
Updated: 06/19/2019 01:58P
Don’t Overlook Biotech IPOs Amidst the Tech Mania
Early-stage biotech companies that have gone public have, on average, raised more money and performed better than biotech companies whose initial public ...
Updated: 06/19/2019 10:59A
Biotech CEO Sheila Gujrathi: best advice for doctors leaving medicine
Sheila Gujrathi trained as a physician at Stanford and Harvard before deciding "to shift careers and explore alternate career paths," she said in an interview.
Updated: 06/18/2019 09:21A
Biotech ETFs are breaking out—here are 3 ways to play the space
Pfizer's deal to buy Array BioPharma for $10.6 billion has ignited biotech stocks, and there are a few ways to get in on the rally using exchange-traded funds.
Updated: 06/17/2019 03:35P
Immune cell-sequencer Adaptive Biotechnologies plans $200M IPO
Ten years after spinning out from Fred Hutch, Adaptive Biotechnologies is planning a $200 million IPO to help power its diagnostic sequencing tests aimed at the ...
Updated: 06/17/2019 11:50A
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
For biotech stocks, the week was back loaded with multiple conferences scheduled for the later half of the week. Nevertheless, there were volatile moves in ...
Updated: 06/15/2019 12:38P